Reposted by Rosanne Sprute
New AGIHO guideline update on G-CSF prophylaxis in adult cancer patients! Evidence-based recommendations incl. immunotherapy settings, biosimilars & risk stratification to support clinical decision-making.
🔗 pubmed.ncbi.nlm.nih.gov/41570611/
@rosannesprute.bsky.social
#Oncology #Guidelines
pubmed.ncbi.nlm.nih.gov
Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer - PubMed
Comprehensive literature search and expert panel consensus confirm most of the key recommendations of 2014. New recommendations on the use of G-CSF in immunotherapy settings provide insight and support for day-by-day clinical decision making in the care of patients with cancer.